Conformationally-preorganized, miniPEG-containing gamma-peptide nucleic acids

US10160787B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10160787-B2
Application numberUS-201815972494-A
CountryUS
Kind codeB2
Filing dateMay 7, 2018
Priority dateApr 8, 2011
Publication dateDec 25, 2018
Grant dateDec 25, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are γ-PNA monomers, methodology for synthesizing them, and methodology for synthesizing PNA oligomers that incorporate them.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound according to Formula IIIa wherein, Z is selected from the group consisting of hydroxyl (OH), iodine (I), 4-toluenesulfonate and methanesulfonate; R 5 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; P is selected from the group consisting of: 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), benzhydryloxycarbonyl (Bhoc), O-nitroveratryloxycarbonyl (Nvoc), 1-(4,4-dimethyl-2,6-dioxacyclohexylidene)ethyl (Dde), diathiasuccinoyl (Dts), benzothiazole-2-sulfonyl (Bts), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); each of R 11 and R 12 is independently selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene, (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene, provided that at least one of R 11 and R 12 is selected from the group consisting of P 2 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); P 3 selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; x is an integer from 1 to 10, inclusive; and y is an integer from 1 to 9, inclusive. 2. The compound of claim 1 , wherein Z is selected from the group consisting of iodine and hydroxyl; R 11 is —CH 2 —[O(CH 2 ) 2 ] x —OR 8 and R 12 is H, wherein x is an integer from 1 to 4 inclusive; R 5 is selected from the group consisting of hydrogen (H) and methyl; and R 8 is selected from the group consisting of hydrogen, methyl, ethyl, and t-butyl. 3. The compound of claim 2 , wherein Z is hydroxyl, R 5 is hydrogen, R 12 is hydrogen and P is 9-fluorenylmethyloxycarbonyl (Fmoc) or t-butyloxycarbonyl (Boc). 4. The compound of claim 3 having the formula IIIa-1: wherein, P 3 is selected from methyl, ethyl and t-butyl. 5. The compound of claim 4 having the formula IIIa-2 or IIIa-3: 6. The compound of claim 5 , having an optical purity of at least 99% enantiomeric excess (ee). 7. The compound of claim 1 , wherein Z is selected from the group consisting of iodine and hydroxyl; R 11 is H and R 12 is —CH 2 —[O(CH 2 ) 2 ] x —OR 8 , wherein x is an integer from 1 to 4 inclusive; R 5 is selected from the group consisting of hydrogen (H) and methyl; and R 8 is selected from the group consisting of hydrogen, methyl, ethyl, and t-butyl. 8. The compound of claim 7 , wherein Z is hydroxyl, R 5 is hydrogen, R 11 is hydrogen and P is 9-fluorenylmethyloxycarbonyl (Fmoc) or t-butyloxycarbonyl (Boc). 9. The compound of claim 8 , having the formula IIIa-4: wherein, P 3 is selected from methyl, ethyl and t-butyl. 10. The compound of claim 9 , having the formula IIIa-5 or IIIa-6: 11. The compound of claim 10 , having an optical purity of at least 99% enantiomeric excess (ee). 12. The compound of claim 1 , wherein Z is hydroxyl (—OH). 13. The compound of claim 1 , wherein Z is iodine (I), 4-toluenesulfonate or methanesulfonate. 14. A method comprising: a) contacting a compound of formula X: wherein, P is selected from the group consisting of: 9-fluorenylmethyloxycarbonyl (Fmoc), t-butyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), benzyl (Bn), tosylate (Tos), allyloxycarbonyl (alloc), trityl (Trt), monomethoxytrityl (MMT) and dimethoxytrityl (DMT); R 5 is selected from the group consisting of hydrogen (H), linear or branched (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 1 -C 8 )hydroxylalkyl, (C 3 -C 8 )aryl, (C 3 -C 8 )cycloalkyl, (C 3 -C 8 )aryl(C 1 -C 6 )alkylene and (C 3 -C 8 )cycloalkyl(C 1 -C 6 )alkylene; one of R 1 and R 2 is —CH 2 —OH and the other of R 1 and R 2 is H with a compound of formula: P 3 —(O—CH 2 —CH 2 —) x OX, wherein X is CH 3 S(O) 2 —, P 3 is methyl, ethyl, or t-butyl; and x is a number from 1 to 10, inclusive, to thereby obtain a compound of formula XI: wherein one of R 11 and R 12 is —CH 2 —O—(CH 2 —CH 2 —O)x-P 3 and the other of R 11 and R 12 is H; and b) reducing the carboxylic acid of formula XI to an alcohol to thereby produce a compound of formula 15. The method of claim 14 , further comprising: c) contacting said compound of formula with a reagent selected from the group consisting of: methanesulfonyl chloride, 4-toluenesulfonyl chloride and sodium iodide. 16. The method of claim 14 , wherein the compound of formula IIIa-7 has the formula IIIa-1: wherein, P 3 is selected from methyl, ethyl and t-butyl. 17. The method of claim 16 , wherein the compound of formula IIIa-1 has the formula IIIa-2 or IIIa-3: 18. The method of claim 14 , wherein the compound of formula IIIa-7 has the formula IIIa-4: wherein, P 3 is selected from methyl, ethyl and t-butyl. 19. The method of claim 18 , wherein the compound of formula IIIa-4 has the formula IIIa-5 or IIIa-6:

Assignees

Inventors

Classifications

  • using activating agents {(C07K1/003, C07K1/006 take precedence)} · CPC title

  • one oxygen and one nitrogen atom, e.g. guanine · CPC title

  • to carbon atoms of acyclic carbon skeletons · CPC title

  • as doubly bound oxygen atoms or as unsubstituted hydroxy radicals · CPC title

  • to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10160787B2 cover?
Described are γ-PNA monomers, methodology for synthesizing them, and methodology for synthesizing PNA oligomers that incorporate them.
Who is the assignee on this patent?
Univ Carnegie Mellon
What technology area does this patent fall under?
Primary CPC classification C07K14/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).